Dupilumab_Metastatic NSCLC

Clinical trial NCT05013450 · COMPLETED

Trial details

NCT number: NCT05013450
Sponsor: Thomas Marron
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2021-09-10
Primary completion: 2025-09-11
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.